These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21424067)

  • 1. Nuclear comparative morphometric study between DCIS and normal resting mammary gland tissue.
    Deacu M; Aşchie M; Boşoteanu M; Petcu L
    Rom J Morphol Embryol; 2011; 52(1 Suppl):303-8. PubMed ID: 21424067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pure ductal carcinoma in situ and in situ component of ductal invasive carcinoma of the breast. A preliminary morphometric study.
    Giardina C; Serio G; Lepore G; Lettini T; Dalena AM; Pennella A; D'Eredità G; Valente T; Ricco R
    J Exp Clin Cancer Res; 2003 Jun; 22(2):279-88. PubMed ID: 12866579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative study of breast cancer progression: different pathways for various in situ cancers.
    Mariuzzi L; Mombello A; Granchelli G; Rucco V; Tarocco E; Frank D; Davis J; Thompson D; Bartels H; Mariuzzi GM; Bartels PH
    Mod Pathol; 2002 Jan; 15(1):18-25. PubMed ID: 11796837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear cytometric changes in breast carcinogenesis.
    Mommers EC; Poulin N; Sangulin J; Meijer CJ; Baak JP; van Diest PJ
    J Pathol; 2001 Jan; 193(1):33-9. PubMed ID: 11169513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer.
    Mariuzzi L; Mombello A; Rucco V; Morelli L; Zamò A; Thompson D; Vaught L; Bartels HG; Mariuzzi G; Bartels PH
    Adv Clin Path; 2000 Apr; 4(2):87-97. PubMed ID: 11080789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in quantitative nuclear features between ductal carcinoma in situ (DCIS) with and without accompanying invasive carcinoma in the surrounding breast.
    Susnik B; Worth A; Palcic B; Poulin N; LeRiche J
    Anal Cell Pathol; 1995 Jan; 8(1):39-52. PubMed ID: 7734410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast.
    Hoque A; Lippman SM; Boiko IV; Atkinson EN; Sneige N; Sahin A; Weber DM; Risin S; Lagios MD; Schwarting R; Colburn WJ; Dhingra K; Follen M; Kelloff GJ; Boone CW; Hittelman WN
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):249-59. PubMed ID: 11303595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphometric analysis of nuclear variations in normal and neoplastic mammary ductal cells].
    Parada D; Farías RM; García-Tamayo J
    Invest Clin; 1999 Dec; 40(4):233-44. PubMed ID: 10666950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of nuclear morphometry with pathologic parameters in ductal carcinoma in situ of the breast.
    Tan PH; Goh BB; Chiang G; Bay BH
    Mod Pathol; 2001 Oct; 14(10):937-41. PubMed ID: 11598161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extent of ductal carcinoma in situ within and surrounding invasive primary breast carcinoma.
    Crombie N; Rampaul RS; Pinder SE; Elston CW; Robertson JF; Ellis IO
    Br J Surg; 2001 Oct; 88(10):1324-9. PubMed ID: 11578285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. bcl-2 expression in the spectrum of preinvasive breast lesions.
    Siziopikou KP; Prioleau JE; Harris JR; Schnitt SJ
    Cancer; 1996 Feb; 77(3):499-506. PubMed ID: 8630957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
    Sasano H; Frost AR; Saitoh R; Matsunaga G; Nagura H; Krozowski ZS; Silverberg SG
    Anticancer Res; 1997; 17(3C):2001-7. PubMed ID: 9216657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nipple aspirate fluid cytology in breast carcinoma.
    Krishnamurthy S; Sneige N; Thompson PA; Marcy SM; Singletary SE; Cristofanilli M; Hunt KK; Kuerer HM
    Cancer; 2003 Apr; 99(2):97-104. PubMed ID: 12704689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Some morphometric parameters of nucleoli and nuclei in invasive ductal breast carcinomas in women].
    Karpinska-Kaczmarczyk K
    Ann Acad Med Stetin; 2009; 55(1):90-6. PubMed ID: 20349598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of nuclear morphometric variables as prognostic predictors in breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Anticancer Res; 1991; 11(4):1663-9. PubMed ID: 1746922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
    Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S
    Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review.
    van Deurzen CH; Hobbelink MG; van Hillegersberg R; van Diest PJ
    Eur J Cancer; 2007 Apr; 43(6):993-1001. PubMed ID: 17300928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.